Stocks making the biggest moves midday: Nike, Rent-A-Center, Carnival Cruise


People walk near the entrance to Nike store, May 25, 2022 in Moscow, Russia.

Konstantin Zavrazhin | Getty Images News | Getty Images

Check out the companies making headlines in midday trading.

Nike — Nike shares dropped 12.8% after the sneaker giant said Thursday its inventory was overstocked, up 44% in its latest quarter. As a result it will offer more discounts to clear out the excess merchandise. Other retailers were also dragged down, with Lululemon Athletica and Under Armour losing almost 6% and nearly 5% respectively.

Rent-A-Center — Shares of Rent-A-Center slipped 21.6% after the company slashed its current-quarter earnings guidance, saying that economic conditions have weighed on consumer traffic and payment patterns.

Carnival Cruise — Shares of Carnival Cruise plunged 23.3% after the company forecast a loss for the fourth quarter, saying high fuel prices and inflation will delay its return to profitability. Royal Caribbean and Norwegian Cruise Lines also slipped, falling 13% and 18%, respectively.

Micron — Shares of Micron rose 1.7% after the company reported quarterly earnings that beat Wall Street expectations, even though sales fell. The chipmaker also gave a weaker-than-expected revenue outlook, saying sales are being hit by slowing consumer demand.

Charles River Laboratories — Charles River shares rose 3.6% after Jefferies upgraded the stock to buy from hold, citing the company’s potential in animal studies.

Twitter — Shares of Twitter rose 2.6% after texts between its founder, Jack Dorsey, and Elon Musk were released in court filings. The Tesla CEO is embroiled in a legal battle over his bid to buy the social media company.

Nucor — Shares of steel company Nucor jumped 1.6% after it announced plans to spend $425 million expanding a galvanized steel line at its South Carolina plant.

Amylyx Pharmaceuticals — Shares of the pharmaceutical company dropped 6.8% despite the stock rallying after hours Thursday on news of the Food and Drug Administration approving its controversial Lou Gehrig’s disease drug.

Generac — Shares of Generac gained 2.3% after Cowen initiated coverage of the company with a buy rating. The generator company is a clear industry winner and has value in its solar offering.

— CNBC’s Alex Harring and Michelle Fox contributed reporting.



Source link

Related articles

The highest 6 media/leisure startups from Disrupt Startup Battlefield

Yearly, TechCrunch’s Startup Battlefield pitch contest attracts hundreds of candidates. We whittle these functions all the way down to the highest 200 contenders, and of them, the highest 20 compete on the large...

XRP’s 2025 Wins Didn’t Ship $5 Value: 2026 Outlook Unsure

In 2025, the XRP neighborhood celebrated the long-awaited decision of the SEC lawsuit, the launch of a number of US-based spot ETFs, and a surge in Ripple partnerships. But, the coveted $5 value...

Liquidity, Clearer Laws and Extra: Crypto Executives Are Bullish for Bitcoin in 2026

Bitcoin ended 2025 with a adverse return. Nonetheless, trade insiders are actually bullish on the cryptocurrency’s efficiency in 2026. Invoice Barhydt, CEO of crypto alternate and pockets firm Abra, believes that easing financial...

SpaceX, OpenAI, and Anthropic may IPO in 2026; these three offers alone would exceed the entire proceeds from roughly 200 US IPOs in 2025...

Featured Podcasts The Speak Present With John Gruber: '2025 12 months in Overview', With Rene Ritchie The director's commentary observe for Daring Fireball. Lengthy digressions on Apple, know-how, design, motion pictures, and extra. Subscribe to The Speak...

Gabon strengthens regional power engagement

Sosthène Nguema Nguema, Minister of Oil and Gasoline, Gabon has been confirmed as a speaker on the upcoming Libya Power & Financial Summit 2026 – going down in Tripoli from January 24-26. The...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com